Eli Lilly & Co (LLY)

$913.31 1.70 (0.19%)

19:00 EST LLY Stock Quote Delayed 30 Minutes

7 Cutting-Edge Stocks That Could Change Humanity as We Know It

By Joel Baglole, InvestorPlace Contributor Oct 16, 2023

Investors wanting exposure to companies whose technology is changing the world should consider these cutting-edge stocks.

7 Stocks to Buy With Your 2024 Social Security Increase

3 Biotech Stocks Ready to Break Out in 2024

Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024

Volume:

Previous Close $901.80

Market Cap 821.83B

PE Ratio 77.97

EPS 11.7139

Volume (Avg. Vol.) 2.93M

Day's Range $896.60 - $922.43

52-Week Range $710.07 - $969.31

Dividend & Yield $5.40 (0.59%)

LLY Stock Predictions, Articles, and Eli Lilly & Co News

Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns

By John Blankenhorn, InvestorPlace Contributor Oct 2, 2023

These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector.

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor Sep 28, 2023

The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020.

Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher

By Muslim Farooque, InvestorPlace Contributor Sep 26, 2023

With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.

David vs. Goliath: 3 Stocks Poised to Challenge the ‘Magnificent 7′

By Alex Sirois, InvestorPlace Contributor Sep 23, 2023

These three stocks are legitimate challengers to the dominance of the Magnificent 7 stocks as we move toward the end of 2023.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor Sep 22, 2023

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

The 7 Most Hated Stocks by Institutional Traders

By Josh Enomoto, InvestorPlace Contributor Sep 20, 2023

Discover the surprising stocks institutional traders are selling, and find out what their moves could mean for your portfolio's future.

Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold

By Joel Baglole, InvestorPlace Contributor Sep 11, 2023

Excitement is building around the potential health and financial benefits of these new weight-loss medications.

3 Nasdaq Stocks to Sell in September Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Sep 7, 2023

These Nasdaq stocks to sell are all risky plays with uncertain futures. It's a good idea to sell or trim your positions in them now.

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

By Louis Navellier and the InvestorPlace Research Staff Sep 7, 2023

Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook.

7 A-Rated Blue-Chip Stocks to Secure Your Financial Future

By Louis Navellier and the InvestorPlace Research Staff Aug 31, 2023

Blue-chip stocks earn that moniker because they're doing something right – they have a track record of success that investors find appealing.

7 Stocks Sitting At 52-Week Highs Right Now

By Joel Baglole, InvestorPlace Contributor Aug 30, 2023

While the broader market has taken a breather in August, it hasn't stopped a select number of stocks from continuing their march higher. Propelled by strong earnings and upbeat guidance, the shares of several leading companies are now at their highest level in a year.

Eli Lilly & Co (LLY)

7 Cutting-Edge Stocks That Could Change Humanity as We Know It

7 Stocks to Buy With Your 2024 Social Security Increase

3 Biotech Stocks Ready to Break Out in 2024

Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Eli Lilly & Co (LLY)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LLY Stock Predictions, Articles, and Eli Lilly & Co News

Subscriber Sign in